Commercial production platform
A scalable proprietary production platform
Based on the research at Eindhoven University of Technology (TU/e), Vabrema B.V. has designed a scalable proprietary production platform that can be used in research, industrial and therapeutic applications. Both in-house and external tests demonstrated increased proliferation rates of various cell types by a factor of 2 to 3, without negatively affecting viability. If you'd like to find out if your cell culture can be boosted, please contact us.
The cost-effective production problem
Promising solutions in the lab often appear less promising once they have to be produced in large quantities.
There are many autologous and allogeneic cell & tissue therapies that hold great potential. However, the large scale, cost-effective production needed for actual application, often proves to be difficult. Factors such as a limited supply of raw materials, low amplification factors and highly labor intensive production inflate production prices. Vabrema develops solutions that enable cost-effective upscaling.ECPR(TM) technology
Increase proliferation rate without interfering with the process.
Eindhoven University of Technology (TU/e), in The Netherlands, has discovered a method to increase the proliferation rate of cells during cell culturing procedures, called ECPR. The method is based on research into the effects of electromagnetic fields on the interior structures of biological cells.
